US OptionsDetailed Quotes
RIGL241220P37000
- 0.00
- 0.000.00%
15min DelayTrading Dec 16 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest37.00Strike Price0.00Turnover486.93%IV-93.01%PremiumDec 20, 2024Expiry Date17.83Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8462Delta0.0241Gamma1.04Leverage Ratio-0.2698Theta-0.0033Rho-0.88Eff Leverage0.0048Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet